Works matching IS 02692813 AND DT 2018 AND VI 48 AND IP 11/12
Results: 29
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1171, doi. 10.1111/apt.15080
- Publication type:
- Article
Letter: is microwave ablation superior to radiofrequency ablation for early stage hepatocellular carcinoma? Authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Editorial: direct anti‐viral agents, hepatitis C virus eradication, and gut‐liver axis—another mechanistic piece to the puzzle.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients—authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Systematic review with meta‐analysis: defecography should be a first‐line diagnostic modality in patients with refractory constipation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1186, doi. 10.1111/apt.15039
- By:
- Publication type:
- Article
Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma—authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Editorial: FibroTest to predict liver‐related mortality in NAFLD. Should this change the diagnostic algorithm in NAFLD?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn's disease of the pouch.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1251, doi. 10.1111/apt.15034
- By:
- Publication type:
- Article
Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease—personalised medicine in its infancy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1213, doi. 10.1111/apt.15033
- By:
- Publication type:
- Article
Editorial: treating strictures in inflammatory bowel disease—authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Letter: chronic kidney disease risk in patients with chronic hepatitis B—authors' reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Editorial: "real world data" of AIH—time to connect!
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Letter: vedolizumab drug concentrations in neonates following intrauterine exposure.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Loss of paraspinal muscle mass is a gender‐specific consequence of cirrhosis that predicts complications and death.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Letter: is microwave ablation superior to radiofrequency ablation for early‐stage hepatocellular carcinoma?
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Editorial: stepwise risk stratification for both F3 and F4 fibrosis stage in NAFLD patients.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Editorial: microbial translocation and immune activation profiling during treatment of chronic HCV.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Editorial: anxiety and depression associated with mucosal healing in coeliac disease.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1282, doi. 10.1111/apt.15020
- By:
- Publication type:
- Article
Systematic review: the consequences of psychosocial effects of inflammatory bowel disease on patients′ reproductive health.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1202, doi. 10.1111/apt.15019
- By:
- Publication type:
- Article
Response to treatment is more important than disease severity at diagnosis for prediction of early relapse in new‐onset paediatric Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1242, doi. 10.1111/apt.15016
- By:
- Publication type:
- Article
The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1260, doi. 10.1111/apt.15015
- By:
- Publication type:
- Article
Persistent damage on magnetic resonance enterography in patients with Crohn's disease in endoscopic remission.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1232, doi. 10.1111/apt.15013
- By:
- Publication type:
- Article
Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1290, doi. 10.1111/apt.15011
- By:
- Publication type:
- Article
Letter: chronic kidney disease risk in patients with chronic hepatitis B.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Systematic review with network meta‐analysis: the impact of medical interventions for moderate‐to‐severe ulcerative colitis on health‐related quality of life.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1174, doi. 10.1111/apt.15005
- By:
- Publication type:
- Article
Influence of hepatitis C virus eradication with direct‐acting antivirals on the gut microbiota in patients with cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1301, doi. 10.1111/apt.15004
- By:
- Publication type:
- Article
Editorial: treating strictures in inflammatory bowel disease.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor